Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence

[1]  Stephen M. Husbands,et al.  Structural insights into μ-opioid receptor activation , 2015, Nature.

[2]  R. Neubig,et al.  Differential Control of Opioid Antinociception to Thermal Stimuli in a Knock-In Mouse Expressing Regulator of G-Protein Signaling-Insensitive Gαo Protein , 2013, The Journal of Neuroscience.

[3]  M. von Zastrow,et al.  Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance , 2013, Pharmacological Reviews.

[4]  B. Yoburn,et al.  [35S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord , 2012, Pharmacology Biochemistry and Behavior.

[5]  M. Morgan,et al.  Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human , 2011, British journal of pharmacology.

[6]  E. Jutkiewicz,et al.  Mu-Opioid Receptor Coupling to Gαo Plays an Important Role in Opioid Antinociception , 2011, Neuropsychopharmacology.

[7]  J. Traynor,et al.  Gi/o-Coupled Receptors Compete for Signaling to Adenylyl Cyclase in SH-SY5Y Cells and Reduce Opioid-Mediated cAMP Overshoot , 2011, Molecular Pharmacology.

[8]  D. Fink,et al.  The Role of TNFα in the Periaqueductal Gray During Naloxone-Precipitated Morphine Withdrawal in Rats , 2011, Neuropsychopharmacology.

[9]  M. Morgan,et al.  Tolerance to the Antinociceptive Effect of Morphine in the Absence of Short-Term Presynaptic Desensitization in Rat Periaqueductal Gray Neurons , 2010, Journal of Pharmacology and Experimental Therapeutics.

[10]  J. Mogil,et al.  Gnao1 (GαO protein) is a likely genetic contributor to variation in physical dependence on opioids in mice , 2009, Neuroscience.

[11]  M. Morgan,et al.  Tolerance to Repeated Morphine Administration Is Associated with Increased Potency of Opioid Agonists , 2008, Neuropsychopharmacology.

[12]  W. Ling,et al.  A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal. , 2008, Drug and alcohol dependence.

[13]  M. Christie.  Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction , 2008, British journal of pharmacology.

[14]  J. Traynor,et al.  Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice. , 2008, European journal of pharmacology.

[15]  D. Filliol,et al.  Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity , 2008, Neuropharmacology.

[16]  D. Selley,et al.  Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors. , 2007, European journal of pharmacology.

[17]  D. Selley,et al.  Region‐dependent attenuation of μ opioid receptor‐mediated G‐protein activation in mouse CNS as a function of morphine tolerance , 2007, British journal of pharmacology.

[18]  R. Mortensen,et al.  Go but not Gi2 or Gi3 is required for muscarinic regulation of heart rate and heart rate variability in mice. , 2007, Biochemical and biophysical research communications.

[19]  M. Fanselow,et al.  Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice , 2006, Pharmacology Biochemistry and Behavior.

[20]  A. Gintzler,et al.  Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules. , 2006, Life sciences.

[21]  J. Traynor,et al.  Comparison of the in vitro efficacy of μ, δ, κ and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes , 2006, Brain Research.

[22]  M. Olmstead,et al.  Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor–G protein coupling and Gβγ signaling , 2005, Neuroscience.

[23]  E. E. Bagley,et al.  Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine , 2005, British journal of pharmacology.

[24]  K. Moriyama,et al.  Age-Dependent Opioid Escalation in Chronic Pain Patients , 2005, Anesthesia and analgesia.

[25]  E. E. Bagley,et al.  GABA Transporter Currents Activated by Protein Kinase A Excite Midbrain Neurons during Opioid Withdrawal , 2005, Neuron.

[26]  M. Morgan,et al.  Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat , 2005, Pain.

[27]  Marc G Caron,et al.  Desensitization of G protein-coupled receptors and neuronal functions. , 2004, Annual review of neuroscience.

[28]  W. Sadee,et al.  Basal Signaling Activity of μ Opioid Receptor in Mouse Brain: Role in Narcotic Dependence , 2004, Journal of Pharmacology and Experimental Therapeutics.

[29]  R. Polakiewicz,et al.  Behavioral/systems/cognitive Brain Region-specific Mechanisms for Acute Morphine- Induced Mitogen-activated Protein Kinase Modulation and Distinct Patterns of Activation during Analgesic Tolerance and Locomotor Sensitization Opioid-receptor Activation in Cell Lines Results in Phosphorylation of P42/ , 2022 .

[30]  D. Brunzell,et al.  The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Morgan,et al.  Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance , 2003, Neuroscience.

[32]  Jon T. Willie,et al.  Involvement of the Lateral Hypothalamic Peptide Orexin in Morphine Dependence and Withdrawal , 2003, The Journal of Neuroscience.

[33]  B. Yoburn,et al.  Role of Giα2‐protein in opioid tolerance and μ‐opioid receptor downregulation in vivo , 2003 .

[34]  G. Pasternak,et al.  Genetic Dissociation of Opiate Tolerance and Physical Dependence in δ-Opioid Receptor-1 and Preproenkephalin Knock-Out Mice , 2002, The Journal of Neuroscience.

[35]  J. Mogil,et al.  Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence , 2002, Neuroscience.

[36]  J. Mogil,et al.  Genetic variation in morphine analgesic tolerance A survey of 11 inbred mouse strains , 2002, Pharmacology Biochemistry and Behavior.

[37]  C. Coscia,et al.  Chronic Morphine-Induced Changes in μ-Opioid Receptors and G Proteins of Different Subcellular Loci in Rat Brain , 2002, Journal of Pharmacology and Experimental Therapeutics.

[38]  H. Akil,et al.  Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal , 2002, Neuroscience.

[39]  T. George,et al.  The Neurobiology of Opioid Dependence: Implications for Treatment , 2002, Science & practice perspectives.

[40]  J. Pintar,et al.  Morphine tolerance and dependence in nociceptin/orphanin fq transgenic knock-out mice , 2001, Neuroscience.

[41]  S. Childers,et al.  Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cord , 2001, Brain Research.

[42]  P. Sánchez-Blázquez,et al.  Administration of myr+-Gi2α subunits prevents acute tolerance (tachyphylaxis) to mu-opioid effects in mice , 2001, Neuropharmacology.

[43]  J. Thome,et al.  Upregulation of Galanin Binding Sites and GalR1 mRNA Levels in the Mouse Locus Coeruleus Following Chronic Morphine Treatments and Precipitated Morphine Withdrawal , 2000, Neuropsychopharmacology.

[44]  K. Shen,et al.  Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions , 2000, Brain Research.

[45]  G. Pasternak,et al.  Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect. , 1998, The Journal of pharmacology and experimental therapeutics.

[46]  J. Traynor,et al.  Tolerance to μ‐opioid agonists in human neuroblastoma SH‐SY5Y cells as determined by changes in guanosine‐5′‐O‐(3‐[35S]‐thio)triphosphate binding , 1997, British journal of pharmacology.

[47]  E. Nestler,et al.  Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment , 1997, Brain Research.

[48]  B. Kest,et al.  An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice , 1996, Brain Research Bulletin.

[49]  Brigitte L. Kieffer,et al.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.

[50]  D. Selley,et al.  Effects of chronic morphine administration on mu opioid receptor- stimulated [35S]GTPgammaS autoradiography in rat brain , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[51]  J. Traynor,et al.  Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. , 1995, Molecular pharmacology.

[52]  E. Nestler,et al.  A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function , 1991, Brain Research.

[53]  T. Yaksh,et al.  Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. , 1989, The Journal of pharmacology and experimental therapeutics.

[54]  E. Nestler,et al.  Regulation of G proteins by chronic morphine in the rat locus coeruleus , 1989, Brain Research.

[55]  J. Traynor,et al.  Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes. , 2006, Brain research.

[56]  B. Yoburn,et al.  Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo. , 2003, Synapse.

[57]  J T Williams,et al.  Cellular and synaptic adaptations mediating opioid dependence. , 2001, Physiological reviews.

[58]  P. Sánchez-Blázquez,et al.  Administration of myr(+)-G(i2)alpha subunits prevents acute tolerance (tachyphylaxis) to mu-opioid effects in mice. , 2001, Neuropharmacology.

[59]  H. Loh,et al.  Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.

[60]  P. Sánchez-Blázquez,et al.  Antibodies directed against alpha subunits of Gi, Gx/z, GO and GS transducer proteins reduced the morphine withdrawal syndrome in mice. , 1994, Life sciences.

[61]  M Farrell,et al.  Opiate withdrawal. , 1994, Addiction.

[62]  M. Farrell,et al.  Opiate withdrawal : Withdrawal syndrome , 1994 .

[63]  C. Severini,et al.  Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice. , 1989, Drug and alcohol dependence.

[64]  T. Jensen,et al.  Chapter 28 Sites of action of opiates in production of analgesia , 1988 .